Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Endocrinology
|
October 11, 2008
Competitive inhibition of organic anion transporting polypeptide 1c1-mediated thyroxine transport by the fenamate class of nonsteroidal antiinflammatory drugs
Daniel E Westholm, David D Stenehjem, Jon N Rumbley, et al.
Hepatology Communications
|
August 3, 2023
High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy
Elizabeth S Aby, Tsung-Hua Shen, Meena N Murugappan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 24, 2018
Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports
Jeffrey A Gilreath, Mei Wei, Shilpa Paul, et al.
European Journal of Hospital Pharmacy : Science and Practice
|
March 6, 2020
Comparative efficacy and safety of interventions for preventing chemotherapy-induced oral mucositis in adult cancer patients: a systematic review and network meta-analysis
Preyanate Wilairat, Kirati Kengkla, Thanatchai Kaewpanan, et al.
Clinical Genitourinary Cancer
|
June 3, 2018
Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma
Andrew W Hahn, Camryn Froerer, Sidney VanAlstine, et al.
NPJ Breast Cancer
|
January 23, 2026
Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States
Pegah Farrokhi, Leah Park, Weston Schmutz, et al.
NPJ Breast Cancer
|
April 8, 2026
Biomarker, treatment patterns, and survival differences in metastatic triple-negative breast cancer by race in the United States
Pegah Farrokhi, Leah Park, Howard Weston Schmutz, et al.
The Oncologist
|
November 29, 2015
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer
David D Stenehjem, Brandon K Bellows, Kraig M Yager, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
|
December 1, 2017
Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis
Yelena P Wu, David D Stenehjem, Lauri A Linder, et al.
BMC Health Services Research
|
March 9, 2018
Impact of a genetic counseling requirement prior to genetic testing
David D Stenehjem, Trang Au, Amy M Sainski, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Endocrinology
|
October 11, 2008
Competitive inhibition of organic anion transporting polypeptide 1c1-mediated thyroxine transport by the fenamate class of nonsteroidal antiinflammatory drugs
Daniel E Westholm, David D Stenehjem, Jon N Rumbley, et al.
Hepatology Communications
|
August 3, 2023
High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy
Elizabeth S Aby, Tsung-Hua Shen, Meena N Murugappan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 24, 2018
Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports
Jeffrey A Gilreath, Mei Wei, Shilpa Paul, et al.
European Journal of Hospital Pharmacy : Science and Practice
|
March 6, 2020
Comparative efficacy and safety of interventions for preventing chemotherapy-induced oral mucositis in adult cancer patients: a systematic review and network meta-analysis
Preyanate Wilairat, Kirati Kengkla, Thanatchai Kaewpanan, et al.
Clinical Genitourinary Cancer
|
June 3, 2018
Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma
Andrew W Hahn, Camryn Froerer, Sidney VanAlstine, et al.
NPJ Breast Cancer
|
January 23, 2026
Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States
Pegah Farrokhi, Leah Park, Weston Schmutz, et al.
NPJ Breast Cancer
|
April 8, 2026
Biomarker, treatment patterns, and survival differences in metastatic triple-negative breast cancer by race in the United States
Pegah Farrokhi, Leah Park, Howard Weston Schmutz, et al.
The Oncologist
|
November 29, 2015
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer
David D Stenehjem, Brandon K Bellows, Kraig M Yager, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
|
December 1, 2017
Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis
Yelena P Wu, David D Stenehjem, Lauri A Linder, et al.
BMC Health Services Research
|
March 9, 2018
Impact of a genetic counseling requirement prior to genetic testing
David D Stenehjem, Trang Au, Amy M Sainski, et al.
Page
of 5